Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diterpenoids from Isodon enanderianus.

Zhi Na1, Wei Xiang, Xue-Mei Niu

  • 1Laboratory of Phytochemistry, Kunming Institute of Botany, Academia Sinica, Kunming, 650204, Yunnan, People's Republic of China.

Phytochemistry
|May 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liquid photonic-molecule microlasers for ultrasensitive biosensing.

Nature communications·2026
Same author

Leucophyllusins A-H: new abietane, pimarane, and ent-kaurane diterpenoids from Isodon leucophyllus.

Fitoterapia·2025
Same author

Discovery and Semisynthesis of Aurantiacin A: A Unique Ascorbylated 9-<i>epi</i>-<i>ent</i>-Kaurane Diterpenoid from the Untapped Plant <i>Isodon aurantiacus</i>.

Organic letters·2025
Same author

Silvaticusins A-D: ent-kaurane diterpenoids and a cyclobutane-containing ent-kaurane dimer from Isodon silvaticus.

Natural products and bioprospecting·2024
Same author

Structurally diverse ent-clerodanoids from the aerial parts of Isodon scoparius.

Phytochemistry·2024
Same author

Isoxerophilusins A and B, Two Novel Polycyclic Asymmetric Diterpene Dimers from <i>Isodon xerophilus</i>: Structural Elucidation, Modification, and Inhibitory Activities against α-Glucosidase.

Organic letters·2024
Same journal

Five undescribed compounds isolated from Gerbera delavayi with their anti-inflammatory activity.

Phytochemistry·2026
Same journal

Ingenane diterpenoids with anti-inflammatory activity from the whole plants of Euphorbia peplus.

Phytochemistry·2026
Same journal

Discovery of cytotoxic 1,4-benzodioxane oxyneolignan analogues from Glechoma longituba.

Phytochemistry·2026
Same journal

Cinnamolides A-G, seven previously undescribed phytoconstituents from the peels of Cinnamomum chago and their anti-inflammatory activity.

Phytochemistry·2026
Same journal

Antiviral amide derivatives from Uvaria siamensis.

Phytochemistry·2026
Same journal

COX-2 inhibitors from Laportea bulbifera: Structure-activity relationship, kinetic investigation, and molecular docking.

Phytochemistry·2026
See all related articles

Four new ent-kauranoid diterpenoids were isolated from Isodon enanderianus. One compound, 6-epiangustifolin, demonstrated significant cytotoxic activity against K562 cells, indicating potential therapeutic applications.

Area of Science:

  • Natural Product Chemistry
  • Phytochemistry
  • Medicinal Chemistry

Background:

  • Isodon enanderianus is a plant source of diverse diterpenoids.
  • Diterpenoids are known for their wide range of biological activities.

Purpose of the Study:

  • To isolate and characterize new ent-kauranoid diterpenoids from Isodon enanderianus.
  • To evaluate the cytotoxic activity of the isolated compounds.

Main Methods:

  • Isolation of compounds using chromatographic techniques.
  • Structure elucidation using spectroscopic data, particularly 2D NMR.
  • Cytotoxicity assay against K562 cell line.

Main Results:

  • Four new ent-kauranoids: 6-epiangustifolin, enanderinanin F, enanderinanin G, and enanderinanin H were identified.

Related Experiment Videos

  • Eleven known ent-kaurane diterpenoids were also isolated.
  • 6-Epiangustifolin exhibited significant cytotoxic activity against K562 cells.
  • Conclusions:

    • The aerial parts of Isodon enanderianus are a rich source of novel ent-kauranoid diterpenoids.
    • 6-Epiangustifolin shows promise as a cytotoxic agent for potential anti-cancer drug development.